Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL2828447 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL4342494 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL204190 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL2381055 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL20569310 | 0.92 | — | — | |
| Trifluoroacetic Acid SCHEMBL282294 | 0.92 | — | — | |
| Trifluoroacetic Acid SCHEMBL20569660 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL20571141 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL20541013 | 0.92 | CA4 (0.38) | CA4CA2CA1CASP1FAHD1 | |
| Trifluoroacetic Acid SCHEMBL7870567 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4646506-A1 | SHAPE-CONTROLLED SYNTHESIS OF III-V COLLOIDAL NANOCRYSTALS | Quantum Science Ltd (GB) | 2025-11-12 | — | — | EP | claimed |
| US-12435033-B2 | Method and device for preparing adiponitrile | ZHEJIANG NHU COMPANY LTD (CN) | 2025-10-07 | — | — | US | claimed |
| CN-115808462-B | Method for eliminating ammonia gas signal and/or volatile organic amine in ion mobility spectrometry and method for detecting sample | 海能基石技术有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-114890667-B | Neutral borosilicate glass medical tube with light shielding function and preparation method thereof | 晓恩医药包装材料(安庆)有限公司 | 2024-07-12 | — | — | CN | claimed |
| WO-2024147019-A1 | SCALABLE SYNTHESIS OF III-V NANOCRYSTALS | QUANTUM SCIENCE LTD (GB) | 2024-07-11 | — | — | WO | claimed |
| WO-2024147018-A1 | SHAPE-CONTROLLED SYNTHESIS OF III-V COLLOIDAL NANOCRYSTALS | QUANTUM SCIENCE LTD (GB) | 2024-07-11 | — | — | WO | claimed |
| CN-116426277-B | Pure green up-conversion luminescent nano material and preparation method thereof | 浙江大学 | 2024-01-09 | — | — | CN | claimed |
| CN-116426277-A | Pure green up-conversion luminescent nano material and preparation method thereof | 浙江大学 | 2023-07-14 | — | — | CN | claimed |
| CN-115808462-A | Method for eliminating ammonia gas signal and/or volatile organic amine in ion mobility spectrometry and method for detecting sample | 苏州盖世生物医疗科技有限公司 | 2023-03-17 | — | — | CN | claimed |
| US-20230035875-A1 | METHOD AND DEVICE FOR PREPARING ADIPONITRILE | ZHEJIANG NHU COMPANY LTD (CN) | 2023-02-02 | — | — | US | claimed |
| US-20060252955-A1 | Process of synthesis of compounds having nitrile functions from ethylenically unsaturated compounds | RHODIA POLYAMIDE INTERMEDIATES | 2006-11-09 | — | — | US | claimed |
| US-7084293-B2 | Process of synthesis of compounds having nitrile functions from ethylenically unsaturated compounds | RHODIA POLYAMIDES INTERMEDIATES (FR) | 2006-08-01 | — | — | US | claimed |
| US-20060128980-A1 | Method for making nitrile compounds from ethylenically unsaturated compounds | INVISTA NORTH AMERICA SARL | 2006-06-15 | — | — | US | claimed |
| US-20060100455-A1 | Hydrocyanating an unsaturated aliphatic nitrile, or a linear pentenenitrile in a liquid medium with hydrogen cyanide in the presence of a Nickel catalyst with an triaryl phosphite ligand; isomerization | INVISTA NORTH AMERICA SARL | 2006-05-11 | — | — | US | claimed |
| US-20060052624-A1 | Making nitrile compounds from ethylenically unsaturated compounds | INVISTA NORTH AMERICA SARL | 2006-03-09 | — | — | US | claimed |
| WO-2006009662-A2 | METHODS FOR GENERATING AND RECYCLING METAL HALIDE CATALYST COMPOSITIONS FOR AROMATIC RING ALOGENATION | GENERAL ELECTRIC COMPANY (US) | 2006-01-26 | — | — | WO | claimed |
| US-20050283034-A1 | Methods for recycling catalyst compositions for aromatic ring halogenation | GENERAL ELECTRIC COMPANY | 2005-12-22 | — | — | US | claimed |
| US-20040122251-A1 | Process of synthesis of compounds having nitrile functions from ethylenically unsaturated compounds | RHODIA POLYAMIDE INTERMEDIATES (FR) | 2004-06-24 | — | — | US | claimed |
| US-20030135016-A1 | Contains a Lewis acid metal salt and a compound having clathrating ability. | TOAGOSEI CO., LTD. | 2003-07-17 | — | — | US | claimed |
| US-6547985-B1 | Adhesive mixture | TOGOSEI CO., LTD. (JP) | 2003-04-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100455-A1 | Hydrocyanating an unsaturated aliphatic nitrile, or a linear pentenenitrile in a liquid medium with hydrogen cyanide in the presence of a Nickel catalyst with an triaryl phosphite ligand; isomerization | DBF4, NUCB2, NCF1 | CA4 731/4885CA2 1309/4885CA1 1275/4885 |
| US-12435033-B2 | Method and device for preparing adiponitrile | ADIPOR2, ADIPOR1, ALKBH1 | CA4 3382/4885CA2 3487/4885CA1 4379/4885 |
| US-20050283034-A1 | Methods for recycling catalyst compositions for aromatic ring halogenation | PRKACG, HCN4, CLIC4 | CA4 347/4885CA2 208/4885CA1 1141/4885 |
| US-20060128980-A1 | Method for making nitrile compounds from ethylenically unsaturated compounds | C9, NISCH, HMOX1 | CA4 1097/4885CA2 2423/4885CA1 1495/4885 |
| US-20040122251-A1 | Process of synthesis of compounds having nitrile functions from ethylenically unsaturated compounds | DBN1, NCSTN, NOS2 | CA4 1928/4885CA2 2210/4885CA1 347/4885 |
| US-20230035875-A1 | METHOD AND DEVICE FOR PREPARING ADIPONITRILE | ADIPOR2, ADIPOR1, ALKBH1 | CA4 3382/4885CA2 3487/4885CA1 4379/4885 |
| US-20060052624-A1 | Making nitrile compounds from ethylenically unsaturated compounds | DBN1, HMOX1, C9 | CA4 1455/4885CA2 2672/4885CA1 1922/4885 |
| US-20060252955-A1 | Process of synthesis of compounds having nitrile functions from ethylenically unsaturated compounds | DBN1, ACHE, DDT | CA4 1693/4885CA2 1486/4885CA1 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.